Skip to main content
. Author manuscript; available in PMC: 2007 Sep 17.
Published in final edited form as: Pharmacogenet Genomics. 2006 Dec;16(12):891–899. doi: 10.1097/01.fpc.0000236324.96056.16

Table 2.

T-786C and E298D genotype frequency by incident coronary heart disease (CHD) or stroke case status

Caucasian African-American
Genotypea Noncases Incident cases P-value Noncases Incident cases P-value
CHD
E298D
G/G 279 (47.2%) 365 (46.7%) 242 (77.3%) 182 (80.2%)
G/T + T/T 336 (52.8%) 416 (53.3%) P=0.862 70 (22.7%) 45 (19.8%) P=0.437
T-786C
T/T 248 (42.3%) 276 (37.4%) 212 (68.4%) 155 (74.9%)
T/C + C/C 362 (57.7%) 463 (62.7%) P=0.079 91 (31.6%) 52 (25.1%) P=0.126
Stroke
E298D
G/G 296 (47.0%) 70 (46.7%) 255 (78.5%) 86 (74.1%)
G/T + T/T 364 (53.0%) 80 (53.3%) P=0.939 68 (21.5%) 30 (25.9%) P=0.362
T-786C
T/T 268 (42.5%) 56 (39.2%) 223 (69.7%) 66 (60.6%)
T/C + C/C 386 (57.5%) 87 (60.8%) P=0.466 90 (30.3%) 43 (39.5%) P=0.099
a

Genotype data presented as absolute (percent) genotype frequency, and weighted according to sampling fraction.